B2DB — Who said what, where, and when

CRISPR screening in patient-derived intestinal organoids for inflammatory bowel disease target discovery at the FGSL - Antigoni Gogolou

ELRIG Drug Discovery 2026 · 14 October 2026 · 14:40–15:10 · Tech Theatre

CRISPR screening in patient-derived intestinal organoids for inflammatory bowel disease target discovery at the FGSL - Antigoni Gogolou was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 1 speaker on record.

Speakers